** Shares in pharma cannabinoid products developer JUPW.O
rise 4.4% to $1.41
** Jupiter Wellness agrees to buy peer Next Frontier to beef
up its pharmaceutical cannabinoids and psychedelics portfolio urn:newsml:reuters.com:*:nACSf5fRna
** Next Frontier's stockholders will be entitled to get JUPW
convertible stock that can be converted into 65 mln JUPW common
shares - Jupiter Wellness
** Jupiter Wellness adds it has loaned $10.2 mln to Next
Frontier in connection with the deal, which in the first full
year of combined ops will add to its earnings
** The deal is expected to close in Q1 2022
** JUPW shares have lost nearly three-fourths of their
market value this year
(Reporting by Praveen Paramasivam)
((Praveen.Paramasivam@thomsonreuters.com;))